(1)
Agarwal, R.; Goel, A.; Rai, J.; Kajal, N. C. Pharmacovigilance of First Line Anti-Tubercular Therapy in Category I Patients of Pulmonary Tuberculosis. Int J Basic Clin Pharmacol 2017, 6, 643-647.